Abstract
It is the common practice of organic chemists who are concerned with the discovery of new drugs to take some compound which is known, or has been unexpectantly found, to possess some interesting or clinically desirable pharmacological properties, as a model, and to study the effect of making relatively small changes in its structure. The simplest chemical change that can be made is to alter the size of an alkyl group or of a polymethylene chain; in other words to investigate the pharmacology of a homologous series. An investigation of this type not only has practical advantages, such as ease of preparation of homologues, the small changes in physical and chemical properties involved, etc. but also it has frequently led to the discovery of highly active drugs. Moreover there is the theoretical likelihood that a detailed study of homologous compounds may reveal mechanisms of drug action which could not be revealed by a study of drugs differing more fundamentally in structure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. J. Clark, General Pharmacology, Hefter’s Handbuch der Exp. Pharmakol., Ergänzungswerk Vol. 4 (1937).
W. D. M. Paton, Proc. Roy. Soc. (Lond.) 154 B (1961), 21.
A. J. Clark, Arch. int. Pharmacodyn. 38 (1930), 301.
J. Ferguson, Proc. Roy. Soc. (Lond.) 127 B (1939), 387.
L. J. Mullins, Chem. Rev. 54 (1954), 289.
H. R. Ing, G. S. Dawes, and I. Wajda, J. Pharmacol. 85 (1945), 85.
A. H. Ford-Moore and H. R. Ing, J. Chem. Soc. 1947, 55.
G. Barger, Some Applications of Organic Chemistry to Biology and Medicine (McGraw-Hill, New York 1930).
E. R. Loew and A. Micetich, J. Pharmacol. 95 (1949), 448.
H. Eagle, J. Pharmacol. 85 (1945), 265; U.S. Pub. Health Repts. 59 (1944), 765.
J. H. Quastel and W. R. Woolrigde, Biochem. J. 21 (1927), 1224.
A. Simonart, J. Pharmacol. 46 (1932), 157.
H. R. Ing, P. Kordik, and D. P. H. Tudor-Williams, Brit. J. Pharmacol. 7 (1952), 103.
A. Simonart, J. Pharmacol. 50 (1934), 1.
H. R. Ing, Science 109 (1949), 264.
L. M. Sturge and V. P. Whittaker, Biochem. J. 47 (1950), 518
L. A. Mounter and V. P. Whittaker, Biochem. J. 47 (1950), 525.
A. K. Armitage and H. R. Ing, Brit. J. Pharmacol. 9 (1954), 376.
H. Blaschko and J. Hawkins, Brit. J. Pharmacol. 5 (1950), 625.
H. Blaschko and R. Duthie, Biochem. J. 39 (1945), 347.
H. King, E. M. Lourie, and Warrington Yorke, Ann. trop. Med. Parasitol. 32 (1938), 177.
A. T. Fuller, Biochem. J. 36 (1942), 548.
W. A. Broom, J. Pharmacol. 57 (1936), 81.
G. S. Dawes, Brit. J. Pharmacol. 1 (1946), 21.
E. M. Lourie and Warrington Yorke, Ann. trop. Med. Parasitol. 33 (1939), 289.
W. D. M. Paton and E. J. Zaimis, Brit. J. Pharmacol. 4 (1949), 381.
R. Wien, D. F. J. Mason, N. D. Edge, and G. T. Langston, Brit. J. Pharmacol. 7 (1952), 534.
R. Wien and D. F. J. Mason, Brit. J. Pharmacol. 8 (1953), 306.
E. W. Gill, Proc. Roy. Soc. (Lond.) 150 B (1959), 381.
E. Schlittler, J. Drucy, and A. Marxer, Progress in Drug Research, Vol. 4 (1962), p. 295.
D. F. J. Mason and R. Wien, Brit. J. Pharmacol. 10 (1955), 124.
R. B. Barlow and H. R. Ing, Brit. J. Pharmacol. 3 (1948), 298.
D. Bovet, F. Bovet-Nitti, S. Guarino, V. G. Longo, and M. Marotta, Rend. Istituto Super. Sanità 12 (1949), 106.
O. J. Magidson and I. Th. Strukow, Arch. Pharm. 271 (1933), 569.
J. Magidson, O. S. Madajewa, and M. W. Rutzow, Arch. Pharm. 273 (1935), 320.
G. A. H. Buttle, T. A. Henry, W. Solomon, J. W. Trevan, and R. M. Gibbs, Biochem. J. 32 (1938), 47.
C. G. Raison and O. D. Standen, Brit. J. Pharmacol. 10 (1955), 191.
see_also: A. G. Caldwell and O. D. Standen, Brit. J. Pharmacol. 11 (1956), 367.
F. J. Buckle, F. L. M. Pattison, and B. C. Saunders, J. Chem. Soc. 1949, 1471.
G. Barger and H. H. Dale, J. Physiol. 41 (1910), 19.
R. P. Ahlquist, Am. J. Physiol. 153 (1948), 586.
P. Pratesi, Pure and Appl. Chem. 6 (1963), 435.
R. W. Taft, Jr., J. Am. chem. Soc. 75 (1953), 4231.
R. P. Stephenson, Brit. J. Pharmacol. 11 (1956), 379.
J. Raventós, Quart. J. exp. Physiol. 26 (1936–1937), 361.
A. J. Clark and J. Raventós, Quart. J. exp. Physiol. 26 (1937), 375.
H. O. Schild, Brit. J. Pharmacol. 2 (1947), 189, 251. 4 (1949), 277.
W. D. M. Paton, Proc. Roy. Soc. (London) 154 B (1961), 21.
E. J. Ariëns, Arch. Int. Pharmacodyn. 99 (1954), 32, 175, 193.
J. M. van Rossum and F. G. van den Brink, Arch. Int. Pharmacodyn. 143 (1963), 240.
A. Crum Brown and T. R. Fraser, Trans. Roy. Soc. (Edinburgh) 25 (1868–1869), 151, 693. Proc. Roy. Soc. (Edinburgh) 7 (1872), 663.
F. Kulz, Pflüger’s Arch. 195 (1922), 623.
H. R. Ing and W. M. Wright, Proc. Roy. Soc. (Lond.) 109 B (1931), 337. 114 B (1933), 48.
W. D. M. Paton and D. R. Waud, Curare and Curare-like Agents, Ciba Foundation Study Group 12, 34 (J. & A. Churchill Ltd., London 1962).
A. Stempel and J. A. Aeschlimann, Synthetic Analogs of Physostigmine, Medicinal Chemistry Vol. III, (John Wiley, New York 1956), p. 341.
P. Holton and H. R. Ing, Brit. J. Pharmacol. 4 (1949), 190.
A. D. Welch and M. H. Roefka, J. Pharmacol. 55 (1935), 118.
H. Blaschko and J. M. Himms, Brit. J. Pharmacol. 10 (1955), 451.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1964 Birkhäuser Verlag Basel
About this chapter
Cite this chapter
Ing, H.R. (1964). The Pharmacology of Homologous Series. In: Jucker, E. (eds) Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques. Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrés des recherches pharmaceutiques, vol 7. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7053-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7053-5_5
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7055-9
Online ISBN: 978-3-0348-7053-5
eBook Packages: Springer Book Archive